Federated Hermes, Inc. Talis Biomedical Corp Transaction History

Federated Hermes, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$6.02 - $12.46 $90,300 - $186,900	-15,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$9.62 - $14.56 $9.76 Million - $14.8 Million	-1,015,000 Reduced 98.54%	15,000 $165,000
Q1 2021 May 13, 2021	BUY	$11.2 - $27.8 $11.5 Million - $28.6 Million	1,030,000 New	1,030,000 $13.2 Million

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $47.1M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.